July 4, 2014 / 7:15 AM / 3 years ago

BRIEF-GSK and Theravance says gains approval in Japan for Anoro Ellipta

July 4 (Reuters) - GlaxoSmithKline Plc

* Press_release:anoro ellipta(umeclidinium/vilant erol) gains approval in Japan for the treatment of COPD

* Announced that Japanese Ministry Of Health, Labour And Welfare (MHLW) has approved Anoro Ellipta

* Following this approval, it is expected that launch will take place in Japan in q3 2014.

* Drug for relief of various symptoms due to airway obstruction with chronic obstructive pulmonary diseases

* Theravance is obligated to make a milestone payment of $10 million (USD) to GSK following MHLW approval of UMEC/VI in Japan Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below